New drug duo targets hard-to-treat cancers
Disease control
Recruiting now
This study tests a combination of two experimental drugs, HX009 and IN10018, with or without standard chemotherapy, in people with advanced solid tumors like biliary tract cancer and melanoma that have not responded to prior treatments. The goal is to find the best dose and see h…
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Hanx Biopharmaceuticals, Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC